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Abstract 
 
Background: Cognitive reserve (CR) has been associated with better cognitive 
function and lower risk of depression in older people, yet it remains unclear whether 
CR moderates the association between mood and cognition. This study aimed to 
investigate whether a comprehensive indicator of CR, including education, 
occupation, and engagement in cognitive and social activities, acts as a moderator of 
this association. 
Methods: This was a cross-sectional study utilising baseline data from the Cognitive 
Function and Ageing Study II (CFAS II), a large population-based cohort of people 
aged 65+ in England. Complete data on the measures of CR, mood, and cognition 
were available for 6565 dementia-free individuals. Linear regression models were 
used to investigate the potential modifying effect of CR on the association between 
cognition and mood with adjustment for age, sex and missing data.  
Results: Levels of CR did moderate the negative association between mood and 
cognition; the difference in cognition between those with and without a clinical level 
mood disorder was significantly smaller in the middle (-2.28; 95% CI: -3.65, -0.90) 
and higher (-1.30; 95% CI: -2.46, -0.15) CR groups compared to the lower CR group 
(-4.01; 95% CI: -5.53, -2.49). The individual components of CR did not significantly 
moderate the negative association between mood and cognition.  
Conclusion: These results demonstrate that CR, indexed by a composite score based 
on multiple indicators, can moderate the negative association between lowered mood 
and cognition, emphasising the importance of continuing to build CR across the 
lifespan in order to maintain cognitive health. 
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Introduction 
Dementia and cognitive decline have been associated with increased disability and 
mortality and account for a significant proportion of care expenditure for older people 
(Comas-Herrera et al., 2011; Di Carlo et al., 2000; Langa et al., 2008; Pérès et al., 
2005; St John et al., 2015; Tinetti et al., 2011). In the UK, an earlier analysis has 
suggested that the continued growth of the ageing population will potentially result in 
3.7 million people with cognitive impairment by 2026, which if realised would result 
in greater healthcare costs (Jagger et al., 2009). Given the individual, family, and 
societal burden of dementia and cognitive decline, it is important to identify potential 
risk factors and develop effective strategies for prevention or risk reduction. Indeed, 
estimates suggest 28.2% of the population-attributable risk of developing Alzheimer’s 
disease could be related to potentially modifiable factors (Norton et al., 2014). 
Depression and anxiety are common mood disorders which affect approximately 
10% of people aged 65 or above in Western Europe (McDougall et al., 2007; 
Copeland et al., 2004).  These common mood disorders, especially current experience 
of depression, have been associated with poorer cognitive performance and an 
increased risk of cognitive decline, mild cognitive impairment (MCI), and dementia 
(Diniz et al., 2013; Reppermund et al., 2011; Steffens et al., 2014; Yates et al., 2013). 
A recent meta-analysis has suggested that approximately 10% of dementia cases 
could be prevented if depression is addressed (Norton et al., 2014). In addition, a 
comprehensive review of existing evidence combined with consensus by eight experts 
indicated that there is good evidence that depression is a modifiable risk factor for 
cognitive decline and dementia (Deckers et al., 2015). 
The associations between lowered mood and cognitive decline or dementia may 
be due to a shared underlying mechanism (Byers & Yaffe, 2011; Korczyn & Halperin, 
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2009; Leonard, 2007). Depression in later life and poorer cognitive performance are 
both associated with white matter hyperintensities, hippocampal atrophy, and 
decreases in total brain volume (Ballmaier et al., 2004; Debette & Markus, 2010;  
Elbejjani et al., 2015; Enzinger et al., 2005; Lampe et al., 2003; Nebes et al., 2001; 
O’Brien et al., 2004). These pathological overlaps suggest that perhaps factors that are 
protective against cognitive impairment and decline may also be protective against 
depression in older people and could be of benefit in moderating the association 
between mood and cognition. 
One such factor could be cognitive reserve. Cognitive reserve is built through 
engagement in cognitively engaging activities across the lifespan, including 
educational level, complex occupations and cognitively-stimulating leisure activities 
(Richards & Deary, 2005; Richards & Sacker, 2003; Whalley et al., 2006; Stern 2002; 
2009; 2011). Several reviews indicate that greater cognitive reserve is associated with 
better cognitive performance in healthy older people and a reduced risk of cognitive 
decline and dementia (Fratiglioni & Wang, 2007; Harrison et al., 2015; Meng & 
D’Arcy, 2012; Opdebeeck et al., 2016a; Valenzuela & Sachdev, 2006a; 2006b). 
Higher levels of cognitive reserve have also been associated with reduced levels of 
depressive symptoms (Lorant et al., 2003; Opdebeeck et al., 2016b; Paulson et al., 
2014).  
At present, research into whether cognitive reserve moderates the association 
between mood and cognitive function has produced conflicting results. A review of 
studies assessing whether cognitive reserve moderates the association between mood 
and cognition concluded that there was a potential modifying effect of cognitive 
reserve on the negative association between mood and cognitive function and decline 
but the result was tentative (Opdebeeck et al., 2015a). The results of the individual 
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studies included in this review were varied, ranging from a moderating effect of 
higher education on the negative association between clinical depression and 
cognitive function (Pálsson et al., 1999; Pálsson et al., 2001) to reports that cognitive 
performance decreases as depressive symptoms increase in those with higher but not 
lower levels of education (Geerlings et al., 2000; O’Shea et al., 2014; Santos et al., 
2014). 
 To address the uncertainty in the literature, the aim of this study is to 
investigate the potential modifying effect of cognitive reserve, measured using a 
composite indicator, on the association between cognitive function and mood 
disorders in a contemporary large population-based cohort of older people in England. 
 
Method 
 
Participants 
Participants were drawn from the first wave of the Cognitive Function and Ageing 
Study II (CFAS II, version 3; http://www.cfas.ac.uk/). A total of 7,762 people over 65 
completed the study between 2008 and 2011 in three geographical areas of England - 
Cambridgeshire, Newcastle, and Nottingham - which included both rural and urban 
populations. More detailed information on CFAS II has been reported previously 
(Gao et al., 2015; Matthews et al., 2013). To avoid the potential confounding effect of 
dementia at prevalence and to standardise participant living situation, this study 
excluded those with a diagnosis of dementia or an organicity score of 3 or higher 
based on AGECAT diagnostic algorithms (n=487) and an additional 81 people living 
in institutional settings. This resulted in a sample of 7,194 community-dwelling older 
people without dementia.  
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Measures 
Cognitive reserve  
A composite measure of cognitive reserve, the cognitive lifestyle score (CLS), 
was calculated based on participants’ educational level, primary occupation, and 
engagement in social and cognitive activities in later life. The calculation of this score 
was based on the CLS created in MRC CFAS, the first cohort of the CFAS studies 
(Valenzuela et al., 2011) with the addition of responses to questions about cognitive 
activities, which included the frequency with which participants listen to the radio, 
read newspapers, magazines, or books, play games such as cards or chess, and do 
puzzles and/or crosswords. These questions were added in CFAS II, making it 
possible to investigate current cognitive lifestyle in more detail.  
Educational level was expressed as years of education completed. Occupation 
was assessed in line with the procedure of Valenzuela and colleagues (2011) in that 
the participants’ main occupation was coded in terms of social class grouping (from I 
to V) and socioeconomic grouping (11 to 150), with lower scores indicating more 
complex occupations in each case. These two groupings were then exploded and 
ranked to create an occupational complexity score with a possible range of 1-14, that 
was more fine-grained than either grouping alone. For example, if a person had a 
social class grouping of I and a socioeconomic grouping of 11 they were given an 
occupation score of 1. In another example, a participant with a social class grouping 
of IIIN (skilled non-manual) or IIIM (skilled manual) and a socioeconomic grouping 
between 70 and 80 would be given an occupation score of 9 in this system. Further 
details regarding the combinations used to create each occupation score can be 
obtained from the corresponding author. An additional ranking of 15 was given to 
housewives as these individuals do not receive a formal code in the UK social class 
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ranking system. The ratings were then reversed to be in the same direction as 
education and social and cognitive engagement, with lower scores indicating a less 
active cognitive lifestyle. The later life activity score comprised the three indicators of 
current social engagement as utilised in the CLS created in MRC CFAS (Valenzuela 
et al., 2011) and the seven measures of current participation in cognitive activities 
added in CFAS II. Current participation in each of the cognitive activities was coded 
on a 5-point scale from undertaking the activity once a year or less to undertaking the 
activity every day. Scores for the 10 items were summed to create an overall activity 
score. 
 To enable each of the three sub-scores to contribute equally to determining 
whether a person’s cognitive lifestyle reflected low, medium or high levels of activity, 
the scores were weighted to provide equal distribution across the sub-components. To 
determine the weights of each component the range of scores between the 25th and 
75th percentile were examined, and the weights were calculated to ensure that all three 
components had equal interquartile ranges, allowing each to contribute equally to the 
total CLS. The total CLS was then calculated using the following formula: 
CLS = (3.4 x education) + (2.4 x occupational complexity) + (1 x social and cognitive 
engagement). 
 The CLS was slightly skewed (Skewness = 0.70; Kurtosis = 3.72) suggesting 
that it was not normally distributed. Hence the CLS was divided at the tertile level to 
allow for comparisons between those with lower, medium, and higher cognitive 
lifestyle scores, which can be considered a proxy measure for their levels of cognitive 
reserve. 
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Mood disorders 
Depression and anxiety were assessed using the Geriatric Mental State 
Automated Geriatric Examination Assisted Taxonomy (GMS AGECAT). The GMS is 
a semi-structured interview designed to assess organic and psychiatric disorders in 
older people. The AGECAT programme uses an algorithm to assign diagnoses to 
provide consistency across time and location. The AGECAT assigns scores for 
depression (0 – 5) and anxiety (0 – 5) based on clusters of symptoms. These scores 
were coded into groups of those with no mood disorder (GMS AGECAT for anxiety 
and depression = 0), a sub-threshold mood disorder (GMS AGECAT for anxiety or 
depression = 1-2), or a clinically relevant mood disorder (GMS AGECAT for anxiety 
or depression = 3+). Absence or presence of a subthreshold or clinical level mood 
disorder, rather than of depression or anxiety individually, was chosen due to the 
strong association between depression and anxiety. Additionally, the GMS AGECAT 
uses a hierarchical system to determine a main diagnosis, which may give precedence 
to a diagnosis of depression over a diagnosis of anxiety when overlapping symptoms 
are reported. The GMS AGECAT has demonstrated good concordance with diagnoses 
by trained psychiatrists (Cohen’s Kappa = 0.84, Copeland et al., 1986) and eliminates 
the variability that has been observed with clinical diagnosis (Copeland et al., 2002). 
Cognition 
Cognition was assessed using the Cambridge Cognitive Assessment 
(CAMCOG). The CAMCOG provides an overall score for cognitive function from 
eight subscales - orientation, language, memory, attention, praxis, calculation, abstract 
thinking, and perception. Total scores range from 0 to 107, however as in MRC 
CFAS, total scores on the CAMCOG in this study could range from 0 to 103 
(Williams et al., 2003). The CAMCOG has good inter-rater reliability (r = .97) with 
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92% sensitivity and 96% specificity in detecting cognitive impairment, and avoids the 
ceiling effects seen in other brief neuropsychological assessments (Roth et al., 1986). 
Data analysis 
T-tests and Chi Square tests were used to compare age, sex and mood disorder 
in those with and without missing CAMCOG and CLS information. Inverse 
probability weighting was then used to adjust for non-response in CFAS II (Matthews 
et al., 2013) as well as missing data, with weights calculated by age, sex, depression 
and anxiety levels. 
Weighted linear regression modelling was used to investigate the association 
between cognitive function, cognitive reserve and mood disorder adjusting for age, 
and sex. To examine the potential modifying effect of cognitive reserve on the 
association between cognition and mood, interactions between cognitive reserve 
measures (the overall CLS, and the individual components of education, occupation 
and social/cognitive activity) and mood disorder were included in the regression 
models. All the analyses were carried out using Stata version 13.  
 
Results 
 
The 7194 community dwelling individuals without dementia included 3115 men and 
3450 women, but 629 people had missing CLS or CAMCOG scores. Individuals with 
missing data were significantly more likely to be older, female, and to have a mood 
disorder (Table 1). Among the 6565 people with complete data, the mean CAMCOG 
score was 89.4 (SD = 7.7) with a range between 42 and 103, and the mean CLS was 
86.9 (SD = 16.2).  The CLS ranged from 26.8 to 156.4 with a median score of 84.6.  
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**Table 1 about here** 
 
 Mood disorder was associated with poorer cognitive performance (Table 2). 
Compared to those without mood disorder, lower CAMCOG scores were found in 
people with subthreshold (-1.02; 95% CI: -1.44, -0.60) and clinical (-3.67; 95% 
CI: -4.59, -2.75) levels of mood disorder after adjusting for age, sex and missing data. 
A higher level of cognitive reserve was associated with better cognitive performance. 
Compared to those with low cognitive reserve, people with medium levels of 
cognitive reserve had CAMCOG scores 4.00 points (95% CI: 3.52, 4.48) higher and 
this difference increased to 6.94 (95% CI: 6.48, 7.39) for those with high cognitive 
reserve when adjusted for age, sex and missing data. The relationships between 
cognitive function, cognitive reserve and mood disorder remained significant in the 
full model including all variables, although the effect sizes slightly reduced (Model 4, 
Table 2).        
 
**Table 2 about here** 
 
To investigate whether cognitive reserve modifies the association between 
cognitive function and mood disorder, Table 3 shows differences in CAMCOG scores 
by cognitive reserve and mood disorder levels. In the lower CLS group, those with 
subthreshold (-1.12; 95% CI: -1.91, -0.31) and clinical (-4.01; 95% CI: -5.54, -2.49) 
mood disorder had significantly lower cognitive function scores compared to those 
without mood disorder. However, the strength of the negative association in those 
with clinical mood disorder compared to those without mood disorder was weaker in 
the middle (-2.28; 95% CI: -3.65, -0.90) and higher CLS groups (-1.30; 95% CI: -2.46, 
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-0.15), and these differential relationships achieved statistical significance (p = 0.04; 
Figure 1). Although similar patterns were found for each individual indicator of CR 
(Figure 1), the interaction terms between mood disorder and levels of education, 
occupation and social/cognitive activity did not achieve statistical significance (Table 
3).         
 
**Table 3 about here** 
 
**Figure 1 about here**  
 
The figures also show the extensive variance seen in cognitive performance in 
those with a mood disorder in comparison to those without a mood disorder or with a 
subthreshold mood disorder, regardless of cognitive reserve level.  
 
Discussion 
 
This study investigated whether cognitive reserve moderated the association between 
mood and cognitive function using a population-based study of older people in 
England. The presence of a subthreshold or clinical level mood disorder was 
associated with poorer cognitive performance, while higher levels of cognitive reserve 
were associated with better cognitive performance. Cognitive reserve did moderate 
the negative association between mood disorders and cognitive function. The 
difference in cognitive performance between those with and without a clinical level 
mood disorder was significantly smaller for those with medium or higher levels of 
cognitive reserve than for those with lower cognitive reserve.  
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These results support our previous findings indicating that mild depressive 
symptoms and anxiety are negatively associated with cognitive function in those with 
lower cognitive reserve but not in those with higher cognitive reserve (Opdebeeck et 
al., 2015b). The current study expands upon these previous findings and suggests that 
similar moderating effects of cognitive reserve on the association between mood 
disorders and cognition are found as when self-reported symptoms that are mild and 
do not reach clinical levels are considered. In contrast, the observed effect was the 
opposite of that reported by O’Shea and colleagues (2015) and Geerlings and 
colleagues (2000) who reported that depression was associated with poorer cognitive 
performance and greater decline in those with higher education but not in those with 
lower education. The results also contrasted with several studies that have reported no 
significant interaction effect between proxy measures of cognitive reserve and mood 
on cognition (Bhalla et al., 2005; Wilson et al., 2004).  
One possible explanation could be the differences between the study cohorts. 
CFAS II, a contemporary study of older people in the UK, has shown through 
comparison with earlier findings that there have been improvements in cognitive 
health over the past 20 years (Jagger et al., 2015; Matthews et al., 2013). The baseline 
level of cognitive reserve might be higher in CFAS II compared to other cohorts, for 
instance due to increased levels of education, which may result in a stronger 
moderation effect on the association of mood disorders with poorer cognitive 
performance. Another explanation for these differences is that the current study used a 
combination of life experiences to indicate levels of cognitive reserve while the 
contrasting studies consider only individual proxy measures of cognitive reserve, 
most commonly years of education. However, when we replicated the analysis with 
individual components, rather than lifetime cognitive reserve, the interactions were 
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similar to those found with lifetime cognitive reserve but the individual component 
interactions were smaller and non-significant. These smaller and non-significant 
interactions demonstrate that it is probable that lifetime cognitive reserve has a 
stronger moderation effect than the individual components. 
The design and contemporary nature of the CFAS II cohort allowed us to 
investigate whether cognitive reserve, considered in terms of multiple indicators, 
moderates the association between mood and cognition in several beneficial ways. It 
enabled the consideration of the differences between those with no mood disorder, a 
subthreshold disorder, and those with a clinical level mood disorder rather than low 
levels of depressive symptoms, as seen in several previous studies (Avila et al., 2009; 
Opdebeeck et al., 2015b; O’Shea et al., 2015). In addition, levels of a comprehensive, 
lifetime indicator of cognitive reserve were represented in tertiles rather than using 
dichotomies of individual or combined proxy measures of cognitive reserve as several 
previous studies have done (e.g. Avila et al., 2009; Bhalla et al., 2005; Opdebeeck et 
al., 2015b). This allowed an investigation of the finer detail of the effects of different 
levels of cognitive reserve. Nevertheless, there are several limitations to this study. As 
this was a cross-sectional study, it is not possible to determine the causal directions of 
the observed associations. Future research could consider examining whether a 
comprehensive proxy measure of cognitive reserve, including education, occupation, 
and current activities, moderates the longitudinal association between mood and 
incidence of cognitive impairment and dementia. A more comprehensive 
neuropsychological assessment than was employed here would allow for assessment 
of the effects within different domains of cognitive function and may give a better 
insight into the mechanisms of these associations, especially if combined with a 
longitudinal design. Additionally, there was greater variation in cognitive 
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performance in those with a clinical mood disorder compared to those with no mood 
disorder, irrespective of level of cognitive reserve. This may indicate the operation of 
other influences not accounted for here, which could be investigated in future 
research. Furthermore, depression is generally a relapsing and remitting condition 
with different trajectories of depression showing different relationships with the risk 
of developing dementia (Mirza et al., 2016), indicating that people’s past history of 
depression may be as, if not more, important than their current levels of depression. 
There may also be shared risk factors for, or causes of, both depression and cognitive 
decline or dementia other than cognitive reserve which could help explain the 
association between mood disorders and cognitive function; for example childhood 
nutrition has been associated with both mood and cognitive status in later life (Case & 
Paxson, 2008; Heys et al., 2008; Whalley et al., 2006). 
Stern (2002) theorised that healthy people with higher cognitive reserve are 
better able to cope with increasing task difficulty, while for those with brain damage 
or disease, cognitive reserve allows compensation through the recruitment of alternate 
neural networks or cognitive paradigms. It is possible that a mood disorder increases 
the challenge of cognitive tasks, for example due to reduced attentional control 
(Eysenck et al., 2007), and that those with higher cognitive reserve are better able to 
compensate for this increase in task demands than those with lower cognitive reserve. 
Several studies report increased activation in frontostriatal regions during executive 
function tasks in people with depression compared to those without depression when 
both groups have similar performance levels (e.g. Matsuo et al., 2007; see Pizzaglli, 
2011 for a review), but reduced activation in people with depression when this 
group’s task performance was poorer than that of people without depression (e.g. 
Harvey et al., 2005; Pizzagilli, 2011). As far as we are aware, no study has 
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investigated differences in activation levels in people with and without depression by 
cognitive reserve level, but it is possible that cognitive reserve helps to compensate 
for the potential abnormality of frontostriatal circuit function in people with 
depression. Future research could investigate this possibility by examining the 
differing levels of activation during cognitive tasks in those with higher and lower 
levels of cognitive reserve and with and without a mood disorder. 
Cognitive reserve has previously been described as a fluid construct and it has 
been suggested that it is possible to continue to build on existing reserve throughout 
the lifespan (Richards & Deary, 2005; Richards & Sacker, 2003; Whalley et al., 
2006). Interventions in mid- and later life aimed at increasing cognitive reserve, such 
as incentives to engage in life-long learning programmes or cognitively-complex 
activities, could moderate the negative effect of mood disorders on cognition and 
support the maintenance of cognitive health in later life. 
Conclusion 
The findings of this study suggest that cognitive reserve is not only associated 
with better cognitive function in later life but also moderates the negative association 
between mood disorders and cognitive function. There is growing emphasis being 
placed on strategies to reduce the risk of cognitive decline and dementia and mood 
disorders have been recognised to be important risk factors for dementia. Enhancing 
cognitive reserve over the life course, through strategies such as increasing 
engagement in social and cognitive activities, may mitigate the negative impact of 
mood disorders on cognitive health in later life. 
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 Table 1: Sex, age, education and level of depressive disorder for those included in the 
analysis and those with missing data 
 Included in analysis  
(N = 6565) 
Any missing data on 
cognitive function or 
cognitive reserve 
(N = 629) 
p-value1 
Age (mean (std.))  74.8 (6.8) 78.3 (7.9) <0.01 
Sex (N (%)) Men 3115 (47.4) 202 (32.1) <0.01 
 Women 3450 (52.6) 427 (67.9)  
Depression (N (%)) None 5130 (78.1) 458 (72.8) <0.01 
 Subthreshold 1022 (15.6) 113 (18.0)  
 Clinical case 413 (6.3) 58 (9.2)  
Anxiety (N (%)) None 4452 (67.8) 425 (67.6) 0.03 
 Subthreshold 1971 (30.0) 180 (28.6)  
 Clinical case 142 (2.2) 24 (3.8)  
Mood disorder (N (%)) None 3935 (59.9) 366 (58.2) 0.03 
 Subthreshold 2137 (32.6) 197 (31.3)  
 Clinical case 493 (7.5) 66 (10.5)  
CAMCOG (mean 
(std.)) 
 89.4 (7.7)    
Cognitive lifestyle 
score 
Total 86.9 (16.2)    
(mean (std.)) Education 10.9 (2.5)    
 Occupation 7.6 (3.2)    
 Activity 31.7 (6.2)    
1. p-value for t-test (age) or Chi-square test (other variables) 
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Table 2: Weighted linear regression models for cognitive performance regressed on 
cognitive reserve (CLS) and level of mood disorder  
 
 Model 1 Model 2 Model 3 Model 4 
 Est. (95% CI) Est. (95% CI) Est. (95% 
CI) 
Est. (95% CI) 
Age  -0.40  
(-0.43, -0.37) 
-0.40  
(-0.43, -0.37) 
-0.33  
(-0.36, -
0.30) 
-0.33  
(-0.36, -0.30) 
 p. <0.01 <0.01 <0.01 <0.01 
      
Sex Men (reference) - - - - 
 Women -1.41  
(-1.83, -1.00) 
-0.63 
 (-1.01, -0.25) 
-1.29  
(-1.66, -
0.93) 
-1.10  
(-1.47, -0.73) 
 p. <0.01 <0.01 <0.01 <0.01 
      
Mood 
disorder 
None (reference) - -  - 
 Subthreshold -1.10  
(-1.55, -0.65) 
-1.02  
(-1.44, -0.60) 
 -0.57 
 (-0.96, -0.18) 
 Clinical case -3.72  
(-4.70, -2.74) 
-3.67  
(-4.59, -2.75) 
 -2.77  
(-3.61, -1.91) 
 p. <0.01 <0.01  <0.01 
      
CLS Low (reference) -  - - 
 Middle 4.42  
(3.92, 4.93) 
 4.00  
(3.52, 4.48) 
3.86  
(3.38, 4.34) 
 High 7.77  
(7.29, 8.25) 
 6.94  
(6.48, 7.39) 
6.77  
(6.32, 7.22) 
 p. <0.01  <0.01 <0.01 
p.: p-value of test for heterogeneity 
Model 1: Univariate model 
Model 2: Multivariable model including age, sex and mood disorder 
Model 3: Multivariable model including age, sex and cognitive reserve (CLS) 
Model 4: Multivariable model including age, sex, mood disorder and cognitive 
reserve 
All models were adjusted for missing data 
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Table 3: Changes in cognitive performance by the interaction terms of cognitive reserve level and mood disorder 
 CLS  Education  Occupation  Activity  
 Model 1 Model 2 Model 1 Model 2 Model 1 Model 2 Model 1 Model 2 
Cognitive reserve  Mood disorder Est. (95% 
CI) 
Est. (95% CI) Est. (95% CI) Est. (95% CI) Est. (95% CI) Est. (95% CI) Est. (95% CI) Est. (95% CI) 
Low  None (reference) - - - - - - - - 
 Subthreshold -1.12  
(-1.96, -0.27) 
-1.12  
(-1.91, -0.31) 
-0.84 
(-1.42, -0.27) 
-0.81 
(-1.35, -0.26) 
-1.24 
(-1.99, -0.48) 
-1.12 
(-1.82, -0.43) 
-1.31 
(-2.16, -0.46) 
-1.28 
(-2.08, -0.49) 
 Clinical case -3.89  
(-5.50, -2.28) 
-4.01  
(-5.54, -2.49) 
-3.96 
(-5.19, -2.73) 
-4.01 
(-5.16, -2.86) 
-4.00 
(-5.49, -2.51) 
-3.94 
(-5.34, -2.54) 
-4.02 
(-5.68, -2.36) 
-3.94 
(-5.49, -2.40) 
Middle None 3.92  
(3.28, 4.57) 
3.43  
(2.82, 4.05) 
3.45 
(2.82, 4.09) 
2.84 
(2.25, 3.43) 
2.75 
(2.16, 3.34) 
3.41 
(2.83, 3.99) 
3.69 
(3.05, 4.33) 
3.26 
(2.68, 3.85) 
 Subthreshold 3.48  
(2.76, 4.21) 
3.06  
(2.37, 3.76) 
2.41 
(1.41, 3.41) 
1.94 
(1.03, 2.84) 
1.82 
(1.08, 2.56) 
2.44 
(1.71, 3.16) 
3.15 
(2.44, 3.86) 
2.92 
(2.26, 3.58) 
 Clinical case 1.53  
(0.00, 3.06) 
1.16  
(-0.27, 2.59) 
1.02 
(-0.56, 2.61) 
0.50 
(-0.88, 1.87) 
-0.65 
(-2.41, 1.12) 
-0.09 
(-1.73, 1.55) 
1.06 
(-0.38, 2.51) 
0.89 
(-0.45, 2.22) 
High None 7.17 
 (6.56, 7.78) 
6.23  
(5.65, 4.80) 
5.10 
(4.54, 5.65) 
4.25 
(3.74, 4.75) 
4.35 
(3.73, 4.97) 
4.10 
(3.54, 4.66) 
5.54 
(4.91, 6.18) 
5.05 
(4.47, 5.64) 
 Subthreshold 6.83  
(6.13, 7.53) 
6.06  
(5.41, 6.72) 
4.11 
(3.35, 4.86) 
3.29 
(2.58, 4.00) 
3.64 
(2.93, 4.35) 
3.69 
(3.04, 4.34) 
5.30 
(4.58, 6.01) 
5.04 
(4.36, 5.72) 
 Clinical case 5.57  
(4.28, 6.86) 
4.92  
(3.70, 6.15) 
3.45 
(1.43, 5.47) 
2.81 
(0.78, 4.85) 
1.81 
(0.18, 3.44) 
2.16 
(0.73, 3.59) 
3.13 
(1.53, 4.73) 
2.95 
(1.39, 4.50) 
p-value for interaction terms 0.18 0.04 0.29 0.17 0.68 0.22 0.25 0.07 
Model 1: Univariate model adjusted for missing data 
Model 2: Multivariable model adjusted for age, sex and missing data 
 
 

